Singapore:Â Mystic Pharmaceuticals, US, received key notices of allowance from Asian patent offices in the company's o...
‎Singapore: TriReme Medical's Japanese partner, Century Medical, has received Shonin approval for Glider P...
The Nobel prize for Physiology to two stem cell research scientists in 2012 has firmly put the spotlight on this promisi...
Singapore: Ariad Pharmaceuticals, an emerging global oncology company focused on discovery, development and commercializ...
Singapore:Â Eisai has been able to meet the US FDA's written request requirements for pediatric exclusivity for Aciphe...
Singapore: Abbott announced that it has initiated the Absorb Japan randomized controlled clinical trial to evaluate the ...
Singapore: Japanese multinational Chugai Pharmaceutical has filed a new drug application to the Ministry of Health, Labo...
Singapore: Dr Shinya Yamanaka, director of the Center for iPS Cell Research and Application (CiRA), Kyoto University, ha...
Singapore: Chugai Pharma USA, Berkeley Heights, NJ a wholly owned subsidiary of Chugai Pharmaceutical, Tokyo, Japan, mem...
Singapore: Japan is hosting its first personalised medicine and diagnostics expo in May 14-16, 2014.The Japanese governm...
The aging population in Japan is not only driving the medical care and pharmaceutical industry but also the medical devi...
Singapore: Eribulin, an anticancer drug marketed by Japan-based Eisai under the trade name Halaven, has received reimbur...
Singapore: Eisai has decided to launch its AMPA receptor antagonist Fycompa (perampanel), a first-in-class anti-epilepti...
The pioneering research of Nobel Laureates Sir John Gurdon and Dr Shinya Yamanaka on reprogramming adult stem cells has ...
Singapore: Takeda Global Research and Development, a wholly owned subsidiary of Takeda Pharmaceutical, has filed seven n...
Singapore: Takeda Pharmaceutical and its wholly-owned subsidiary, Takeda Pharmaceuticals USA, have announced that the US...
New Delhi: Aiming at becoming one of the global manufacturing hubs, besides being a large healthcare market, India has i...
Singapore: Japan's top pharma companies, including Astellas, Eisai, Daiichi Sankyo, Shionogi, and Takeda, have come toge...
Singapore: The WHO has prequalified Eisai's drug NTD002, a 100 mg tablet of diethylcarbamazine (DEC) for treatment of el...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: The wholly-owned US subsidiary of Sysmex, Sysmex America, has won the seventh annual Pinnacle Award presented...
Singapore:Â Mr Yoshihiro Arai, currently general manager and head of development of Solasia Pharma, has been promoted ...
Singapore: Medical Device and Diagnostic Industry (MD+DI) recently published an original infographic and supporting arti...
Singapore: The intellectual property and science business of Thomson Reuters has collaborated with Japan's Tohoku Univer...
